Q2 2026 13F filing
Updated 28 days ago43 disclosed positions worth $635.1M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PATH UIPATH INC | $244M | 22.45M | 38.43% | — |
| 2 | P PATH UIPATH INC | $57.2M | 5.26M | 9.01% | — |
| 3 | P PATH UIPATH INC | $35.2M | 3.24M | 5.54% | — |
| 4 | K KGEI KOLIBRI GLOBAL ENERGY INC | $20.6M | 4.15M | 3.24% | — |
| 5 | A AUTL AUTOLUS THERAPEUTICS LTD | $15.2M | 9.50M | 2.39% | — |
| 6 | L LYFT LYFT INC | $14.6M | 1.00M | 2.30% | — |
| 7 | D DFTX DEFINIUM THERAPEUTICS INC | $13.5M | 287.0K | 2.13% | — |
| 8 | K KGEI KOLIBRI GLOBAL ENERGY INC | $13.3M | 2.68M | 2.09% | — |
| 9 | W WK WORKIVA INC | $12.1M | 250.0K | 1.91% | — |
| 10 | C CXM SPRINKLR INC | $11.4M | 2.20M | 1.79% | — |
| 11 | M MBX MBX BIOSCIENCES INC | $11.2M | 203.5K | 1.77% | — |
| 12 | A ALKT ALKAMI TECHNOLOGY INC | $10.9M | 600.3K | 1.71% | — |
| 13 | C CLDX CELLDEX THERAPEUTICS INC NEW | $10.8M | 290.4K | 1.70% | — |
| 14 | R RLAY RELAY THERAPEUTICS INC | $10.7M | 570.3K | 1.68% | — |
| 15 | A ARWR ARROWHEAD PHARMACEUTICALS IN | $10.6M | 130.5K | 1.67% | — |
| 16 | P PHVS PHARVARIS N V | $10.2M | 295.6K | 1.61% | — |
| 17 | A ALKS ALKERMES PLC | $10M | 190.0K | 1.57% | — |
| 18 | I IMVT IMMUNOVANT INC | $9.9M | 255.9K | 1.55% | — |
| 19 | A AXSM AXSOME THERAPEUTICS INC. | $8.6M | 35.0K | 1.35% | — |
| 20 | S SLNCF SILENCE THERAPEUTICS PLC | $8.4M | 764.3K | 1.32% | — |
| 21 | D DYN DYNE THERAPEUTICS INC | $7.9M | 356.7K | 1.25% | — |
| 22 | I IONS IONIS PHARMACEUTICALS INC | $7.7M | 97.2K | 1.21% | — |
| 23 | M MGRB AGIOS PHARMACEUTICALS INC | $7.6M | 205.6K | 1.20% | — |
| 24 | H HRMY HARMONY BIOSCIENCES HLDGS IN | $7.3M | 201.0K | 1.15% | — |
| 25 | K KRYS KRYSTAL BIOTECH INC | $7.3M | 19.7K | 1.15% | — |
| 26 | A ANNX ANNEXON INC | $7.1M | 1.24M | 1.12% | — |
| 27 | C CELC CELCUITY INC | $6.7M | 64.1K | 1.06% | — |
| 28 | N NKTR NEKTAR THERAPEUTICS | $6.1M | 87.0K | 0.96% | — |
| 29 | A AMLX AMYLYX PHARMACEUTICALS INC | $5.4M | 297.9K | 0.84% | — |
| 30 | A ACAD ACADIA PHARMACEUTICALS INC | $4.2M | 167.9K | 0.67% | — |
| 31 | W WMT WARNER BROS DISCOVERY INC | $4.1M | 154.8K | 0.65% | — |
| 32 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $3.3M | 100.0K | 0.53% | — |
| 33 | S SLNCF SILENCE THERAPEUTICS PLC | $3.3M | 300.0K | 0.52% | — |
| 34 | ? N/A CUE BIOPHARMA INC | $3M | 93.8K | 0.47% | — |
| 35 | S SNOW SNOWFLAKE INC | $2.5M | 10.0K | 0.40% | — |
| 36 | W WMT WARNER BROS DISCOVERY INC | $2.5M | 95.2K | 0.40% | — |
| 37 | K KPTI KARYOPHARM THERAPEUTICS INC | $2.4M | 250.3K | 0.39% | — |
| 38 | A ACRS ACLARIS THERAPEUTICS INC | $2.1M | 400.0K | 0.33% | — |
| 39 | M MGRB AGIOS PHARMACEUTICALS INC | $1.9M | 50.0K | 0.29% | — |
| 40 | T TECX TECTONIC THERAPEUTIC INC | $1.6M | 46.5K | 0.25% | — |
| 41 | M MNST MONTE ROSA THERAPEUTICS INC | $1.4M | 56.1K | 0.21% | — |
| 42 | ? N/A TENAX THERAPEUTICS INC | $1.1M | 75.1K | 0.17% | — |
| 43 | A AMLX AMYLYX PHARMACEUTICALS INC | $153K | 8.5K | 0.02% | — |